Clinical trial · Interventional
Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC
Efficacy and Safety of Anticoagulant Therapy for Portal Vein Thrombosis In Cirrhosis Patients With and Without Hepatocellular Carcinoma
NCT07132515CI-TRIAL-00093869recruitingPhase 4ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
We will give an anticoagulant against portal vein thrombosis, and watch for the results.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cirrhosis | — | UNRESOLVED | — |
| HCC - Hepatocellular Carcinoma | — | UNRESOLVED | — |
| Portal Vein Thrombosis | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Enoxaparin, warfarrin, or apixaban | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- EXPERIMENTAL
- label
- Anticoagulant in cirrhosis with HCC
- description
- HCC patient on anticogulant like Enoxaparin (clexan), warfarrin(marivan), or DOAC(apixaban)
- interventionNames
- Drug: Enoxaparin, warfarrin, or apixaban
- type
- EXPERIMENTAL
- label
- Anticoagulant in Cirrhosis without HCC
- description
- Benign thrombus in cirrhotic patient on anticoagulant like Enoxaparin (clexan), warfarrin(marivan), or DOAC(apixaban)
- interventionNames
- Drug: Enoxaparin, warfarrin, or apixaban
- type
- NO_INTERVENTION
- label
- No anticoagualnt in Cirrhosis with or without HCC
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Portal vein thrombosis, Cirrhosis, With or without HCC, Child A \& B Exclusion Criteria: * Platelets\<10000, Createnine \>1.9, Budd ciarri, Uncontrolled active bleeding
References
Publications (0)
Data not yet available
No reference posted for this study.